Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Imbalance in superoxide dismutase/thioredoxin reductase activities in hypercholesterolemic subjects: relationship with low density lipoprotein oxidation.

Augusti PR, Ruviaro AR, Quatrin A, Somacal S, Conterato GM, Vicentini JT, Duarte MM, Emanuelli T.

Lipids Health Dis. 2012 Jun 21;11:79. doi: 10.1186/1476-511X-11-79.

3.
4.

Plasma paraoxonase-1, oxidized low-density lipoprotein and lipid peroxidation levels in gout patients.

Jiang XL, Li M, Zhou JG, Yang QB, Du LJ, Du J.

Cell Biochem Biophys. 2011 Nov;61(2):461-6. doi: 10.1007/s12013-011-9221-5.

PMID:
21748243
5.

[Atorvastatin and oxidized low density lipoprotein antibody. Relationship to age].

Sánchez Muñoz-Torrero JF, Crespo L, Fernández Pereira L, Pereira G, Cámara C, Costo A.

Med Clin (Barc). 2011 Feb 26;136(5):199-201. doi: 10.1016/j.medcli.2010.05.028. Epub 2010 Dec 8. Spanish.

PMID:
21145076
6.

PON1, a new biomarker of cardiovascular disease, is low in patients with systemic vasculitis.

Quéméneur T, Martin-Nizard F, Kandoussi A, Kyndt X, Vanhille P, Hachulla E, Hatron PY, Fruchart JC, Duriez P, Lambert M.

Semin Arthritis Rheum. 2007 Dec;37(3):149-55. Epub 2007 May 21.

PMID:
17512573
7.

Enzymes that hydrolyze adenine nucleotides of patients with hypercholesterolemia and inflammatory processes.

Duarte MM, Loro VL, Rocha JB, Leal DB, Bem AF, Dorneles A, Morsch VM, Schetinger MR.

FEBS J. 2007 Jun;274(11):2707-14. Epub 2007 Apr 19.

8.

Antioxidant status and oxidative stress markers in pancreatic cancer and chronic pancreatitis.

Kodydkova J, Vavrova L, Stankova B, Macasek J, Krechler T, Zak A.

Pancreas. 2013 May;42(4):614-21. doi: 10.1097/MPA.0b013e318288360a.

PMID:
23558240
9.

[Oxidized LDL and lipids as risk factors for ischemic heart disease in type 2 diabetes].

Zamaklar M, Lalić K, Rajković N, Trifunović D, Dragasević M, Popović L, Drasković D, Laić N, Jotić A, Vasović O, Lukić L, Milicić T, Potpara T.

Vojnosanit Pregl. 2005 Jul-Aug;62(7-8):529-36. Serbian.

PMID:
16171015
10.

Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks.

Sumegová K, Blazícek P, Waczulíková I, Zitnanová I, Duracková Z.

Acta Biochim Pol. 2006;53(4):783-7. Epub 2006 Nov 14.

11.

Serum oxidized low density lipoprotein, paraoxonase 1 and lipid peroxidation levels during oral glucose tolerance test.

Serin O, Konukoglu D, Firtina S, Mavis O.

Horm Metab Res. 2007 Mar;39(3):207-11.

PMID:
17373636
12.

Probucol up-regulates paraoxonase 1 expression in hepatocytes of hypercholesterolemic rabbits.

Hong SC, Zhao SP, Wu ZH.

J Cardiovasc Pharmacol. 2006 Jan;47(1):77-81.

PMID:
16424789
13.

Serum paraoxonase phenotype distribution in exudative age-related macular degeneration and its relationship to homocysteine and oxidized low-density lipoprotein.

Javadzadeh A, Ghorbanihaghjo A, Bahreini E, Rashtchizadeh N, Argani H, Alizadeh S.

Retina. 2012 Apr;32(4):658-66. doi: 10.1097/IAE.0b013e31822529b1.

PMID:
22030834
14.

Antioxidant enzymes and paraoxonase show a co-activity in preserving low-density lipoprotein from oxidation.

Sözmen EY, Sözmen B, Girgin FK, Delen Y, Azarsiz E, Erdener D, Ersöz B.

Clin Exp Med. 2001 Dec;1(4):195-9.

PMID:
11918278
15.
16.

Association between moderately oxidized low-density lipoprotein and high-density lipoprotein particle subclass distribution in hemodialyzed and post-renal transplant patients.

Kimak E, Hałabiś M, Baranowicz-Gąszczyk I, Solski J, Książek A.

J Zhejiang Univ Sci B. 2011 May;12(5):365-71. doi: 10.1631/jzus.B1000348.

17.

Comparative effects of high-dose atorvastatin versus moderate-dose rosuvastatin on lipid parameters, oxidized-LDL and inflammatory markers in ST elevation myocardial infarction.

Aydin MU, Aygul N, Altunkeser BB, Unlu A, Taner A.

Atherosclerosis. 2015 Apr;239(2):439-43. doi: 10.1016/j.atherosclerosis.2015.02.003. Epub 2015 Feb 7.

PMID:
25697576
18.

Effect of atorvastatin therapy on oxidant-antioxidant status and atherosclerotic plaque formation.

Sezer ED, Sozmen EY, Nart D, Onat T.

Vasc Health Risk Manag. 2011;7:333-43. doi: 10.2147/VHRM.S17781. Epub 2011 Jun 1.

19.
20.

Oxidized low-density lipoprotein (oxLDL) plasma levels and oxLDL to LDL ratio - are they real oxidative stress markers in dialyzed patients?

Pawlak K, Mysliwiec M, Pawlak D.

Life Sci. 2013 Mar 12;92(4-5):253-8. doi: 10.1016/j.lfs.2012.12.002. Epub 2013 Jan 4.

PMID:
23295961

Supplemental Content

Support Center